Detalhe da pesquisa
1.
Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Nature;
611(7934): 155-160, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36289334
2.
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature;
606(7915): 797-803, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35705814
3.
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
N Engl J Med;
388(9): 813-823, 2023 Mar 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36856617
4.
B cells and tertiary lymphoid structures promote immunotherapy response.
Nature;
577(7791): 549-555, 2020 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31942075
5.
Long-term outcomes (beyond 5 years) of liver transplant recipients-A transatlantic multicenter study.
Liver Transpl;
30(2): 170-181, 2024 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37589505
6.
Utility of next-generation sequencing in the diagnosis of metastatic melanoma: A case report.
J Cutan Pathol;
2024 May 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38757469
7.
Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature;
613(7945): E3, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36627494
8.
Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Nature;
615(7953): E23, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36894629
9.
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.
Oncologist;
28(8): 714-721, 2023 08 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36952233
10.
Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors.
Am J Gastroenterol;
118(9): 1609-1617, 2023 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37307533
11.
Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit.
Cancer;
128(5): 975-983, 2022 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34724197
12.
Increased long-term bleeding complications in females undergoing endovascular revascularization for peripheral arterial disease.
J Vasc Surg;
76(4): 1021-1029.e3, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35700858
13.
Dose-escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF-mutated advanced cancers.
Cancer;
127(3): 391-402, 2021 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33119140
14.
Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies.
Br J Cancer;
124(9): 1533-1539, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33674736
15.
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis.
Br J Cancer;
124(3): 574-580, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33087895
16.
Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma.
Gynecol Oncol;
161(3): 645-652, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33795130
17.
Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series.
Cancer;
126(3): 523-530, 2020 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31658370
18.
Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
Cancer;
125(23): 4193-4202, 2019 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31398264
19.
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
Cancer;
125(3): 463-472, 2019 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30383888
20.
Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma.
Cancer Immunol Immunother;
68(4): 553-561, 2019 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30666357